RA
SEM

Rise Advisors’s Select Medical SEM Stock Holding History

Rise Advisors’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed -$46 – 1192
2025
Q3 		$46 Hold
4
– – ﹤0.01% 1501
2025
Q2 		$54 Hold
4
– – ﹤0.01% 1514
2025
Q1 		$59 Sell
4
-406
-99% -$7.47K ﹤0.01% 1471
2024
Q4 		$7.73K Sell
410
-349
-46% -$6.73K ﹤0.01% 1027
2024
Q3 		$14.3K Buy
759
+4
+0.5% +$77 0.01% 891
2024
Q2 		$14.3K Buy
755
+1
+0.1% +$17 0.01% 855
2024
Q1 		$12.2K Buy
+754
New +$11K 0.01% 989

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Rise Advisors's SEM Position: Q4 2025 in Review

Rise Advisors sold out of Select Medical (SEM) in Q4 2025, closing a stake of 4 shares — an estimated $46 sold.

Rise Advisors first reported a position in SEM in Q1 2024 and held it in 7 quarters. The position peaked at $14.3K in Q2 2024. 268 funds tracked by Wall St. Rank hold SEM as of Q4 2025.

  • Rise Advisors reported no remaining Select Medical position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 4 Select Medical shares in Q4 2025, an estimated $46.
  • Rise Advisors first reported a position in Select Medical in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Select Medical position peaked at $14.3K in Q2 2024.
  • 268 funds tracked by Wall St. Rank held Select Medical as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.